Peer-reviewed veterinary case report
Tolerogenic dendritic cells: promising cell therapy for acute kidney injury.
- Journal:
- Kidney international
- Year:
- 2023
- Authors:
- Nakamura, Yasuna & Inoue, Tsuyoshi
- Affiliation:
- Department of Physiology of Visceral Function and Body Fluid · Japan
Abstract
There is still no established treatment for acute kidney injury (AKI), and the intervention of AKI remains limited to supportive treatments. Li et al. demonstrated the mechanism by which immune tolerance by dendritic cell ameliorates AKI in a mouse ischemia-reperfusion injury model. The phase I/II clinical trials of tolerogenic dendritic cell therapy have been conducted for kidney transplantation, so it is expected to have potential as a cell therapy for AKI in the future.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/37599014/